全文获取类型
收费全文 | 2814篇 |
免费 | 238篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 68篇 |
妇产科学 | 49篇 |
基础医学 | 485篇 |
口腔科学 | 33篇 |
临床医学 | 282篇 |
内科学 | 715篇 |
皮肤病学 | 41篇 |
神经病学 | 211篇 |
特种医学 | 125篇 |
外国民族医学 | 1篇 |
外科学 | 334篇 |
综合类 | 75篇 |
一般理论 | 6篇 |
预防医学 | 220篇 |
眼科学 | 36篇 |
药学 | 173篇 |
中国医学 | 17篇 |
肿瘤学 | 207篇 |
出版年
2023年 | 15篇 |
2022年 | 35篇 |
2021年 | 66篇 |
2020年 | 33篇 |
2019年 | 58篇 |
2018年 | 62篇 |
2017年 | 48篇 |
2016年 | 49篇 |
2015年 | 57篇 |
2014年 | 70篇 |
2013年 | 113篇 |
2012年 | 170篇 |
2011年 | 196篇 |
2010年 | 134篇 |
2009年 | 109篇 |
2008年 | 121篇 |
2007年 | 164篇 |
2006年 | 138篇 |
2005年 | 117篇 |
2004年 | 123篇 |
2003年 | 100篇 |
2002年 | 98篇 |
2001年 | 93篇 |
2000年 | 100篇 |
1999年 | 64篇 |
1998年 | 65篇 |
1997年 | 58篇 |
1996年 | 46篇 |
1995年 | 23篇 |
1994年 | 26篇 |
1993年 | 31篇 |
1992年 | 53篇 |
1991年 | 43篇 |
1990年 | 46篇 |
1989年 | 43篇 |
1988年 | 45篇 |
1987年 | 32篇 |
1986年 | 25篇 |
1985年 | 32篇 |
1984年 | 18篇 |
1983年 | 20篇 |
1982年 | 19篇 |
1981年 | 10篇 |
1980年 | 19篇 |
1979年 | 17篇 |
1978年 | 14篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1974年 | 8篇 |
排序方式: 共有3084条查询结果,搜索用时 15 毫秒
31.
Chloe Miu Mak Ching-Wan Lam Sidney Tam Ching-Lung Lai Lik-Yuen Chan Sheung-Tat Fan Yu-Lung Lau Sik-To Lai Patrick Yuen Joannie Hui Chun-Cheung Fu Ka-Sing Wong Wing-Lai Mak Kong Tze Sui-Fan Tong Abby Lau Nancy Leung Aric Hui Ka-Ming Cheung Chun-Hung Ko Yiu-Ki Chan Oliver Ma Tai-Nin Chau Alexander Chiu Yan-Wo Chan 《Journal of human genetics》2008,53(4):375-375
32.
个体化下肢小腿假肢接受腔设计的生物力学评价技术研究 总被引:3,自引:0,他引:3
作为传递体重、固定假肢的部件 ,接受腔对于小腿假肢使用的舒适性和方便程度有决定性的作用。本研究建立了基于有限元应力分析的小腿假肢生物力学评价技术平台 ,实现了小腿残端 /接受腔 3D几何建模与信息交互、三维有限元自动建模及应力分析。 3D模型与信息交互的实现基于得到广泛支持的OpenGL技术 ,有限元模型的构建采用了专门针对小腿残端 /接受腔结构特点的自动建模方法 ,通过构建档案数据库系统作为整个系统的操作平台。该技术平台可与现有的CAD/CAM系统相结合 ,为接受腔的个体化设计提供生物力学定量化依据。其临床应用将改善传统的设计流程 ,提高设计效率。同时 ,它也是未来构建接受腔设计专家 /智能系统的基础。 相似文献
33.
Tada Y Ho A Koarada S Morito F Ushiyama O Suzuki N Kikuchi Y Ohta A Mak TW Nagasawa K 《Clinical immunology (Orlando, Fla.)》2001,99(3):325-333
TNF is a potent proinflammatory cytokine important for the development of arthritis in human and animals. We have investigated the roles of TNF receptor-1 (TNFR1) and TNF receptor-2 (TNFR2) in collagen-induced arthritis (CIA) by inducing CIA in mice genetically deficient in TNFR1. TNFR1-/- mice developed arthritis with similar incidence and severity as TNFR1+/- littermates, indicating that TNFR1 is redundant for the development of CIA. Anti-type II collagen (CII) antibody levels and T cell responses to CII did not differ between TNFR1-/- mice and controls. Neutralization of TNF with soluble TNF binding protein suppressed the development of arthritis in TNFR1+/- mice but not in TNFR1-/- mice, indicating that TNFR2 cannot substitute for TNFR1 for the proinflammatory function. To further investigate the functions of TNFR2, TNFR1-/- mice were injected with murine TNF-alpha at different stages during the course of CIA. Repeated TNF-alpha injection during the early induction phase enhanced the development of arthritis, but inhibited arthritis when administered during the late progression phase. These results show that the engagement of TNFR2 by TNF is involved in the development of CIA in the absence of TNFR1 and that opposing signals can be transduced by TNFR2. 相似文献
34.
Transgenic Mice as an in vivo Model for Self-Reactivity 总被引:1,自引:0,他引:1
Davto A. Ferrick Pamela S. Ohashi Valerie A. Wallace Marco Schilham Tak W. Mak 《Immunological reviews》1990,118(1):257-283
35.
36.
Evaluation of a recombinant line blot for diagnosis of Epstein-Barr Virus compared with ELISA, using immunofluorescence as reference method 总被引:3,自引:0,他引:3
Gärtner BC Fischinger JM Roemer K Mak M Fleurent B Mueller-Lantzsch N 《Journal of virological methods》2001,93(1-2):89-96
A commercial line blot using recombinant antigens was compared with a commercial ELISA and 'in-house' IFA (reference test). Two panels were evaluated: Panel A was selected to distinguish between primary infections (89), past infections (20) and seronegatives (8) in immunocompetent individuals. In panel B, patients with a high number of reactivations were included: immunosuppressed patients (37), lymphoma (19), nasopharyngeal carcinoma (10), chronic fatigue syndrome (14). Blood donors (43) and cross-reactive sera (29) were added as controls. Line blot and IFA were concordant in 94% of primary infections, 100% of seronegatives and 100% of past infections, similar to ELISA. Results differed significantly with regard to reactivations. When compared with IFA, the incidence of reactivations was overestimated by the blot, 24 and 58% in blood donors and cross-reactive sera, respectively. ELISA showed a similar problems with 21 and 34% indeterminate results, respectively. The line blot is easy to carry out, has a good concordance with the reference IFA for primary infections, and is, therefore, a sufficient choice for distinguishing primary infection from seronegative and past infection. EBV reactivation assessment will require other methods such as EBV viral load. 相似文献
37.
Wai-Ping Fung-Leung Valerie A. Wallace Dawn Gray William C. Sha Hanspeter Pircher Hung-Sia Teh Dennis Y. Loh Tak W. Mak 《European journal of immunology》1993,23(1):212-216
During thymic development, immature thymocytes expressing major histocompatibility complex (MHC) class I-restricted T cell receptors (TcR) differentiate into CD8+ T cells with cytolytic functions. To evaluate the role of CD8 in positive and negative selection during thymic ontogeny, mice rendered CD8-null by gene targeting were bred with three lines of transgenic mice expressing unique MHC class I-restricted TcR. In all three instances CD8 was required for positive selection of MHC class I-restricted transgenic T cells. The efficiency of positive selection decreased in accordance with a reduced level of CD8 expression on thymocytes. Surprisingly, there was a differential requirement for CD8 expression in negative selection of MHC class I-restricted thymocytes, depending on the antigen specificity of TcR. These observations show that CD8 is essential for positive selection but is differentially required for negative selection of MHC class I-restricted T cells. Thus thymic selection, at least for negative selection, can occur in the absence of the CD8 accessory molecule. 相似文献
38.
39.
Founder effect in spinal and bulbar muscular atrophy (SBMA) 总被引:3,自引:2,他引:3
Tanaka F; Doyu M; Ito Y; Matsumoto M; Mitsuma T; Abe K; Aoki M; Itoyama Y; Fischbeck KH; Sobue G 《Human molecular genetics》1996,5(9):1253-1257
We analyzed the polymorphic (CAG)n and (GGC)n repeats of the androgen
receptor gene in 113 unrelated X-linked spinal and bulbar muscular atrophy
(SBMA) X chromosomes and 173 control X chromosomes in Japanese males. The
control chromosomes had an average CAG repeat number of 21 +/- 3 with a
range from 14-32 repeat units, and SBMA chromosomes had a range from 40-55
with a median of 47 +/- 3 copies. The control chromosomes had seven
different alleles of the (GGC)n repeat with the range of 11 to 17; the most
frequent size of (GGC)n was 16 (79%), while (GGC)17 was very rare (1%).
However, in SBMA chromosomes only two alleles were seen; the most frequent
size of (GGC)n was 16 (61%) followed by 17 (39%). (GGC)n size distribution
was significantly different between SBMA and control chromosomes (P <
0.0001), indicating the presence of linkage disequilibrium. There was no
allelic association between the (CAG)n and (GGC)n microsatellites among
control subjects as well as SBMA patients, which suggests that a founder
effect makes a more significant contribution to generation of Japanese SBMA
chromosomes than new mutations.
相似文献
40.
Looi LM Zubaidah Z Cheah PL Cheong SK Gudum HR Iekhsan O Ikram SI Jamal R Mak JW Othman NH Puteri JN Rosline H Sabariah AR Seow HF Sharifah NA;Working Group on Cancer Diagnosis Research 《The Malaysian journal of pathology》2004,26(1):13-27
Cancer is a major morbidity and mortality concern in Malaysia. Based on National Cancer Registry data, the Malaysian population is estimated to bear a cancer burden of about 40,000 new cases per year, and a cumulative lifetime risk of about 1:4. Cancer research in Malaysia has to consider needs relevant to our population, and resources constraints. Hence, funding bodies prioritise cancers of high prevalence, unique to our community and posing specific clinical problems. Cancer diagnosis is crucial to cancer management. While cancer diagnosis research largely aims at improvements in diagnostic information towards more appropriate therapy, it also impacts upon policy development and other areas of cancer management. The scope of cancer diagnosis upon which this paper is based, and their possible impact on other R&D areas, has been broadly categorized into: (1) identification of aetiological agents and their linkages to the development of precancer and cancer (impact on policy development, cancer prevention and treatment), (2) cancer biology and pathogenesis (impact on cancer prevention, treatment strategies and product development), (3) improvements in accuracy, sensitivity and specificity in cancer detection, monitoring and classification (impact on technology development) and (4) prognostic and predictive parameters (impact on treatment strategies). This paper is based on data collected by the Working Group on Cancer Diagnosis Research for the First National Conference on Cancer Research Coordination in April 2004. Data was collated from the databases of Institutions/Universities where the authors are employed, the Ministry of Science, Technology and Innovation (MOSTI) and targeted survey feedback from key cancer researchers. Under the 7th Malaysia Plan, 76 cancer projects were funded through the Intensified Research in Priority Areas (IRPA) scheme of MOSTI, amounting to almost RM15 million of grant money. 47(61.8%) of these projects were substantially in cancer diagnosis, accounting for 65.6% (RM 9.7 million) of cancer project funds. The 8th Malaysia Plan saw a change in research strategy. The IRPA agency fielded several top-down projects which encouraged a multicentre and multidisciplinary approach. This resulted in larger funding per project i.e. RM32 million for 49 projects. There was also a surge of interest in drug development and natural products. Because of this shift in direction, cancer diagnosis projects constituted only 51% of IRPA-funded cancer projects. Nonetheless funding for cancer diagnosis research has exceeded that of the 7th Malaysia Plan, being RM12.5 million by March 2004. The majority of such research is carried out at the Universities, engaging a large number of young scientists and postgraduate students (51 MSc and 21 PhD). A lot of research findings presented at scientific meetings have not yet been published and there is a glaring shortage of patents and commercialization of research findings (such as creation of test kits). Because diagnosis is very much a part of clinical practice, many researchers felt satisfied and confident that their work will be translated into practice and will significantly improve diagnostic services in Malaysia. National guidelines and consensus development on at least three malignancies i.e. breast cancer, oral cancer and lymphoma, have substantial basis in local R&D work. Problems encountered in research included (1) insufficient funding to realize research objectives, (2) lack of local expertise (most research assistants are inexperienced BSc graduates with no or minimal research experience), (3) inadequate technical support from vendors during equipment failure, (4) inexperienced Institutional development units to assist in product development, (5) lack of venture capital for commercialization of findings, and (6) inadequate incentives to undertake research. Researchers pointed out that plans to promote research should include the establishment of (1) regional and national cancer tissue banks, (2) a National Cancer Research Institute, (3) a dedicated cancer research fund, (4) a registry of cancer researchers, (5) national research coordinators, (6) improved coverage by the National Cancer Registry, (7) more international collaboration, (8) a better career structure for researchers, (9) improved Institutional support for product realization, and (10) better recognition for cancer researchers. 相似文献